Glooko CEO Rick Altinger tells MassDevice.com that the future of chronic disease management depends on patient engagement, smarter mobile technologies and industry partnerships.
Silicon Valley mHealth company Glooko is rocketing forward in the mobile diabetes management space since its inception less than 3 years ago, boasting multiple FDA clearances, wide-ranging industry partnerships and a growing base of patient users and healthcare provider subscribers.
Just last month,...
Medtronic CEO Omar Ishrak speaks with MassDevice.com publisher Brian Johnson about an evolving global medical device landscape, the shifting values of consumers and why he’s not too worried about fighting the medical device tax.
Legal analyst Kristian Werling updates MassDevice.com on the 2.3% medical device tax, detailing provisions that are still catching the industry off-guard and explaining why price increases aren't as easy as they sound.
The 2.3% medical device tax has been in effect for about half a year now, meaning some of the myths about the levy are being slowly stripped away.
As it turns out, the retail exemption contained in the IRS codes, protecting over-the-counter...
Allergan CEO David Pyott talks Botox, medical devices and the aesthetics industry in this podcast, recorded at the MassDevice Big 100 West.
Three months before he took the reins at Boston Scientific, Mike Mahoney told MassDevice his thoughts on how he looked to turnaround the medical device giant in this podcast from the MassDevice Big 100 East
Sanovas' new MicroCam plug-and-play endoscopic imaging system paves the way for a paradigm shift toward linear medical devices for natural orifice surgery, CEO Larry Gerrans tells MassDevice.com.
In talking about his company's newly launched MicroCam laparoscopic imaging platform, Sanovas CEO Larry Gerrans tells a story of innovation and, perhaps more importantly, of evolution.
In an interview with MassDevice.com, Gerrans described the "plug-&-play...